Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome
Simon Faissner(St. Josef-Hospital), Ralf Gold(St. Josef-Hospital), Aiden Haghikia(Friedrich-Alexander-Universität Erlangen-Nürnberg), Melissa Sgodzai(St. Josef-Hospital), Roland Schroers(University Hospitals of the Ruhr-University of Bochum), Dominic Borie, Dimitrios Mougiakakos(Otto-von-Guericke-Universität Magdeburg), Christian Geis(Jena University Hospital), Jeremias Motte(St. Josef-Hospital)
Cited by 70
Related Papers
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
|Brain|2011|1.2k
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
|The Lancet Neurology|2019|853
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
|Physiological Reviews|2017|633